FDA Inspection 1274582 — Shanghai Jollin Lab Co., Ltd.
The FDA completed an inspection of Shanghai Jollin Lab Co., Ltd. on May 16, 2025 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shanghai (China)
Additional Details
Bioanalytical BA/BE